There is a general understanding and comfort in management of small, relatively well-defined SCC of the skin, even those that carry some high risk features (PNI, high DOI, high grade, etc).

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management.